Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 6/20 | 0.53 |
| ▸ | POLB | P06746 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | GAA | P10253 | 3/20 | 0.45 |
| ▸ | HPGD | P15428 | 3/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | BRD4 | O60885 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1062502 | 0.80 | LMNA (1.00) | LMNAMAPTPOLBMEN1KMT2A | |
| SCHEMBL1060657 | 0.76 | LMNA (0.73) | LMNAMAPTPOLBMEN1KMT2A | |
| SCHEMBL11276300 | 0.75 | LMNA (0.68) | LMNAMAPTPOLBMEN1KMT2A | |
| SCHEMBL14499342 | 0.73 | POLB (0.76) | LMNAMAPTPOLBMEN1KMT2A | |
| SCHEMBL7823939 | 0.73 | LMNA (0.57) | LMNAMAPTPOLBMEN1KMT2A | |
| SCHEMBL26701843 | 0.72 | CYP1A2 (0.58) | LMNAMAPTPOLBMEN1KMT2A | |
| SCHEMBL7956193 | 0.72 | LMNA (0.56) | LMNAMAPTPOLBMEN1KMT2A | |
| SCHEMBL2075491 | 0.72 | LMNA (0.63) | LMNAMAPTPOLBMEN1KMT2A | |
| SCHEMBL7420866 | 0.71 | HCAR2 (0.50) | LMNAMAPTPOLBMEN1KMT2A | |
| SCHEMBL14499343 | 0.71 | LMNA (0.56) | LMNAMAPTPOLBMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050020644-A1 | Bicyclic fused pyridinyl amides and advantagesous compositons thereof for use as fungicides | E.I. DU PONT DE NEMOURS AND COMPANY | 2005-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050020644-A1 | Bicyclic fused pyridinyl amides and advantagesous compositons thereof for use as fungicides | CBR3, CBR1, PNPO | LMNA 3010/4885MAPT 2739/4885POLB 2598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.